Acute pulmonary thromboembolism after messenger RNA vaccination against coronavirus disease 2019: A case report

Ishibashi, Yoshihiro; Takama, Noriaki; Fujii, Tomoyuki; Takizawa, Daiki; Amanai, Shiro; Kuno, Takahiro; Aihara, Kazufumi; Koitabashi, Norimichi; Ishii, Hideki

doi:10.1016/j.jccase.2023.02.014

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Oman, a 59-year-old woman with diabetes and osteoporosis was diagnosed with pulmonary embolism and deep vein thrombosis seven days after the first dose of the Pfizer vaccine, similarly without thrombocytopenia [ 6 ]. In addition, pulmonary embolism after mRNA vaccination has been reported in several countries ( Table 2 ) [ 4 , 5 , 6 , 13 , 14 , 15 , 16 ].…”

Section: Discussionmentioning

confidence: 99%

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report

Kim

Yoo

2023

Vaccines

View full text Add to dashboard Cite

Pulmonary embolism causes pulmonary vascular obstruction and damages circulation, leading to death in serious cases. Various cases of thrombosis have been reported as adverse reactions after vaccination with COVID-19 vaccines, and reliable studies on thrombosis with thrombocytopenia syndrome (TTS) have been confirmed, especially for viral vector vaccines. However, the association with mRNA vaccines has not been proven. We report a case of pulmonary embolism and deep vein thrombosis that occurred after using mRNA COVID-19 vaccines (BNT162b2).

show abstract